HALE DAVID F
SEC CIK 1024004 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DRMA | Dermata Therapeutics, Inc. | Dir, 10% | 81.0K | — | — | 6 | 2021-08-17 | 2025-01-23 |
Most active insiders at DRMA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bedoya-Toro Munera Maria E | SVP, Regulatory Affairs | $1,270 | — |
| 2 | Scott Kathleen D. | Dir | — | $13.09 |
| 3 | Van Hoose Kyri K. | SVP, CFO | — | — |
| 4 | PROEHL GERALD T | Pres, COB, CEO, Dir, 10% | — | — |
HALE DAVID F made no open-market trades at DRMA in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2025-01-23 | 2025-01-23 | DRMA | Dermata Therapeutics, Inc. | HALE DAVID F | Dir | A - Grant | — | +78.7K | 81.0K | +3,553% | — |
| 2022-10-07 | 2022-10-06 | DRMA | Dermata Therapeutics, Inc. | HALE DAVID F | Dir | A - Grant | $0.00 | +30.2K | 75.7K | +66% | $0 | |
| 2022-07-08 | 2022-07-07 | DRMA | Dermata Therapeutics, Inc. | HALE DAVID F | Dir | A - Grant | $0.00 | +26.4K | 45.6K | +138% | $0 | |
| 2022-04-08 | 2022-04-07 | DRMA | Dermata Therapeutics, Inc. | HALE DAVID F | Dir | A - Grant | $0.00 | +15.5K | 19.1K | +423% | $0 | |
| DMI | 2021-08-17 | 2021-08-17 | DRMA | Dermata Therapeutics, Inc. | HALE DAVID F | Dir, 10% | C - Cnv Deriv | — | +278.3K | 331.6K | +522% | — |
| DI | 2021-08-17 | 2021-08-17 | DRMA | Dermata Therapeutics, Inc. | HALE DAVID F | Dir, 10% | P - Purchase | — | +35.7K | 35.7K | New | — |
Purchase Sale Sale after option exercise All abbreviations